Market revenue in 2023 | USD 12.0 million |
Market revenue in 2030 | USD 31.2 million |
Growth rate | 14.7% (CAGR from 2023 to 2030) |
Largest segment | Enzymatic dissociation |
Fastest growing segment | Enzymatic Dissociation |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Non-Enzymatic Dissociation, Instruments & Accessories, Enzymatic Dissociation |
Key market players worldwide | Merck KGaA, Thermo Fisher Scientific Inc, Danaher Corp, Stemcell Holdings Inc Ordinary Shares, Sartorius AG, BD, Miltenyi Biotec, Roche, PAN-Biotech GmbH, HiMedia Laboratories, S2 Genomics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell dissociation market will help companies and investors design strategic landscapes.
Enzymatic dissociation was the largest segment with a revenue share of 47.5% in 2023. Horizon Databook has segmented the Canada cell dissociation market based on non-enzymatic dissociation, instruments & accessories, enzymatic dissociation covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada cell dissociation market , including forecasts for subscribers. This country databook contains high-level insights into Canada cell dissociation market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account